SBRA — Sabra Health Care REIT, Inc. stock price, charts and financials

QT48Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
20.68
-0.36-1.71%
OverviewShort InterestFilings
SBRAQT48Sabra Health Care REIT, Inc.·NASDAQ
20.68-1.71%
Analyst
Down 1.7% — Raymond James upgraded to Market Perform.
High confidence
TA
Loading chart...
Signal & projected range
Analyst upgradeHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
HR-1.18%$19.73NHI-1.25%$74.36MPW+1.52%$5.36CTRE-2.11%$40.35MPT-12.66%$4.11AHR-1.30%$56.00LTC-1.46%$39.27DHC-4.76%$8.40
Snapshot
Index-P/E79.70EPS (ttm)0.26Insider Own1.85%Shs Outstand252.19MPerf Week-0.61%
Market Cap5.31BForward P/E26.73EPS next Y0.79Insider Trans-0.33%Shs Float250.55MPerf Month5.84%
Enterprise Value6.33BPEG-EPS next Q-Inst Own-Short Float9.97%Perf Quarter2.24%
Income65.26MP/S6.17EPS this Y4.04%Inst Trans-Short Ratio8.81Perf Half Y9.70%
Sales859.56MP/B1.93EPS next Y20.10%ROA1.19%Short Interest24.99MPerf YTD11.09%
Book/sh-P/C11.29EPS next 5Y-ROE2.34%52W High22.38 -7.60%Perf Year14.29%
Cash/sh-P/FCF11.93EPS past 3/5Y- -0.91%ROIC22.89%52W Low16.88 22.54%Perf 3Y63.61%
Dividend Est.1.20 (5.80%)EV/EBITDA17.64Sales past 3/5Y7.43% 5.29%Gross Margin72.58%Volatility3.20% 2.89%Perf 5Y13.18%
Dividend TTM1.20 (5.80%)EV/Sales7.36EPS Y/Y TTM16.67%Oper. Margin11.84%ATR (14)0.59Perf 10Y-10.54%
Dividend Ex-DateAug 14, 2026Quick Ratio0.29Sales Y/Y TTM15.65%Profit Margin7.61%RSI (14)53.51Recom2.69
Dividend Gr. 3/5Y0.00% -2.33%Current Ratio0.29EPS Q/Q-56.76%SMA20-0.09%Beta0.63Target Price22.50
Payout571.07%Debt/Eq0.46Sales Q/Q20.65%SMA505.98%Rel Volume0.57Prev Close21.04
Employees58LT Debt/Eq0.83EarningsNov 04SMA2007.17%Avg Volume3.09MPrice20.68
IPO DateApr 02, 2002Option/ShortYes / YesEPS/Sales Surpr.-0.87% 6.00%Net Debt/EBITDA2.85Volume1,761,443Change-1.71%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26UpgradeRaymond JamesUnderperform → Market Perform
Jul-22-26ReiteratedUBSNeutral$22 → $25
Jul-22-26ReiteratedRobert W. Baird$22 → $23
Jul-08-26UpgradeTruist SecuritiesHold → Buy$21 → $22
Jul-07-26ReiteratedBarclaysEqual Weight$21
Jun-23-26DowngradeCitigroupBuy → Neutral
Jun-18-26ReiteratedUBSNeutral$22 → $19
May-21-26ReiteratedScotiabankSector Perform$15 → $22
May-13-26ReiteratedUBSNeutral$21 → $22
May-11-26ReiteratedCantor FitzgeraldNeutral$21 → $22
Latest News
Aug-07-26
Aug-07-2603:55AM
Amundi Increases Stock Holdings in Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net
Aug-04-26
Aug-04-2605:40PM
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcriptseekingalpha.com
03:05PM
Sabra Healthcare REIT Q2 Earnings Call Highlightsmarketbeat.com
Aug-03-26
Aug-03-2608:47PM
Sabra Health Care REIT (NASDAQ:SBRA) Q2 Results Beat on Revenue and AFFO Despite Loan Loss ProvisionChartMill
06:46PM
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimateszacks.com
04:05PM
Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidancebusinesswire.com
Jul-31-26
Jul-31-2612:40PM
HPP vs. SBRA: Which Stock Is the Better Value Option?zacks.com
04:13AM
First Trust Advisors LP Raises Holdings in Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net
Jul-27-26
Jul-27-2604:04AM
Entropy Technologies LP Purchases 93,021 Shares of Sabra Healthcare REIT, Inc. $SBRAdefenseworld.net
Jul-26-26
Jul-26-2609:00AM
The Fed's Crude DilemmaSeekingAlpha
Jul-23-26
Jul-23-2610:00AM
Sabra Health Care REIT, Inc., Publishes Sixth Annual Sustainability Reportgurufocus.com
Jul-22-26
Jul-22-2609:36AM
Strength Seen in Sabra (SBRA): Can Its 10.2% Jump Turn into More Strength?zacks.com
Jul-21-26
Jul-21-2605:33PM
Why Sabra Health Care REIT Stock Soared Todayfool.com
09:05AM
Sabra Issues Business Update and Increases Full-Year 2026 Guidancebusinesswire.com
Jul-20-26
Jul-20-2608:05PM
Sabra Health Care REIT, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference CallYahoo
Company

Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue860775703——————
Cost of Goods Sold Incl. D&A236271227——————
Gross Profit623504476——————
Selling, General and Administrative Excl. Other615450——————
Research and Development
000——————
Other Operating Expense462186169——————
Operating Income102264257——————
Interest Expense88112115——————
Unusual Expense
—————————
Non-Operating Income (Expense)496-14——————
Net Income Before Taxes63157128——————
Income Taxes-121——————
Consolidated Net Income66156127——————
Net Income From Continuing Operations64156127——————
Net Income66156127——————
EPS (Recurring)0.260.640.54——————
EPS (Basic, Before Extraordinaries)0.260.640.54——————
EPS (Diluted)0.260.640.54——————
EBITDA359457413——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio79.5429.5932.07——————
Price To Sales Ratio6.065.895.74——————
Gross Margin72.4465.0367.71——————
Operating Margin11.8634.0636.56——————
Net Margin7.6720.1318.07——————
Shares Outstanding252241233——————
Market Capitalization5,2114,5654,036——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$23.16$21.49$19.81$18.13$16.46● Close Price0.00K75.62K151.24K226.87K302.49KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
FLORES JESSICAExecutive VP & CAOMar 25 '26Sale19.8615,231302,48871,709Mar 26
FOSTER MICHAEL JDirectorMay 20 '25Sale18.2211,000200,37664,725May 22
Cusack CatherineDirectorFeb 24 '25Buy15.921,50023,88060,583Feb 25
Cusack CatherineDirectorFeb 21 '25Buy16.431,00016,43559,083Feb 25
Cusack CatherineDirectorMay 22 '24Buy14.437,000101,01046,385May 23
FOSTER MICHAEL JDirectorMay 14 '24Sale14.6810,000146,83063,923May 17
Costa Michael LourencoExecutive VP, CFO & SecretarySep 01 '23Buy12.631,94724,591183,218Sep 05
Cusack CatherineDirectorFeb 25 '22Buy13.242,00026,48014,994Mar 02
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.